Skip to main content

Glucotrack, Inc.

For the period ended Sep 30, 2025. Filed Nov 13, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 13, 2025

GCTK$1.39-32.2%Stored close · as of Oct 29, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Balance Sheets

(in thousands of US dollars except share data)

September 30, 2025December 31, 2024
Unaudited
Current Assets
Cash and cash equivalents$7,869$5,617
Other current assets237151
Total current assets8,1065,768
Operating lease right-of-use asset, net4059
Property and equipment, net14495
Restricted cash-10
TOTAL ASSETS$8,290$5,932
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)
Current Liabilities
Accounts payable$1,709$992
Operating lease liability, current2826
Convertible promissory notes-5
Promissory note3,031-
Other current liabilities529252
Total current liabilities5,2971,275
Non-Current Liabilities
Derivative financial liabilities (Note 2F and Note 3B)317,421
Operating lease liability, non-current1233
Loans from stockholders227203
Total liabilities$5,539$18,932
Commitments and contingent liabilities (Note 4)-
Stockholders’ Equity (Deficit)
Common Stock of $0.001 par value (“Common Stock”):
250,000,000 and 100,000,000 shares authorized as of September 30, 2025 and December 31, 2024, respectively; 899,410 and 13,409 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively1-(*)
Additional paid-in capital150,690119,230
Receipts on account of shares228228
Accumulated other comprehensive income42(8)
Accumulated deficit(148,210)(132,450)
Total stockholders’ equity (deficit)2,751(13,000)
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)$8,290$5,932
(*)Represents amount lower than $1.
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.